Jeffrey Matos is a Cardiology physician affiliated with New Jersey Institute of Technology. OpenAlex indexes 34 publications with 1,339 citations (h-index 21).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1421 3rd Ave
New York, NY 100281802
Telephone
212-772-6384Registry record last updated 3 Mar 2010.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- BOSTON SCIENTIFIC CORPORATIONProgram year20211 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
68.4%Beta blocker35.2%Metoprolol Succinate100%Part D≥27 patientsAntiarrhythmic17.8%Amiodarone Hcl56%Norpace Cr44%Part D<11 patients+ 2 more classes in this area
Blood & clotting
26.5%Factor Xa inhibitor26.5%Eliquis100%Part D<11 patientsMetabolism & gastrointestinal
5.1%SGLT2 inhibitor5.1%Jardiance100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Evaluating protein incorporation and release in electrospun composite scaffolds for bone tissue engineering applications
Journal of Biomedical Materials Research Part A
2015 - Efficacy and Risks of Moricizine in Inducible Sustained Ventricular Tachycardia
Annals of Internal Medicine
1992
Similar KOLs
Other experts from the same institution or the same specialty.
Gregory Y.H. Lip
Medical University of Białystok
Mika Kivimäki
University of Helsinki
Salim Yusuf
Population Health Research Institute
Victoria Delgado
Institute of Molecular Bioimaging and Physiology
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”